Tadayuki Oshima

35PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersAllergyPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Social epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Mar 13, 2026
Early Therapeutic Response Predicts Outcome in Chronic Constipation: A Multicenter Prospective Observational Study.

Tadayuki Oshima, Seiji Futagami, Yoshimasa Tanaka

|Jan 04, 2024
Regulatory T cells Are Increased and Correlate With Mast Cells in Eosinophilic Esophagitis.

Junji Chen, Tadayuki Oshima, Toshihiko Tomita

|Jan 04, 2024
Mind the Gap: The Realities of Novel Irritable Bowel Syndrome Drug Access in Asian Clinical Practice.

Yong Sung Kim, Tadayuki Oshima, Kewin T H Siah

|Dec 08, 2023
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients.

Takanori Yoshimoto, Tadayuki Oshima, Takashi Fukada

|Aug 31, 2023
How should we interpret the data of eosinophilic esophagitis patients from an academic institution?

Tadayuki Oshima

Pageof 6